BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 37601129)

  • 1. Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?
    Arya S; Ventin M; Nebbia M; Fernandez-Del Castillo C; Lionetto G; Qadan M; Lillemoe KD; Deshpande V; Catalano OA; Thiele EA; Ferrone CR
    Ann Surg Oncol; 2023 Nov; 30(12):7748-7755. PubMed ID: 37648887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Odontogenic myxofibroma of gingiva in a pediatric patient with tuberous sclerosis: A rare case report.
    Bhoyar N; Gupta S; Ghosh S
    Contemp Clin Dent; 2016; 7(4):558-561. PubMed ID: 27994429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberous sclerosis complex combined with primary lymphedema: A case report.
    Li XP; Sun XL; Liu X; Wen Z; Jiang LH; Fu Y; Yue YL; Wang RG
    World J Clin Cases; 2024 May; 12(15):2642-2648. PubMed ID: 38817219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant Koenen Tumors as the Presenting and Only Clinical Sign of Tuberous Sclerosis Complex in a 56-Year-Old Man and Its Surgical Management.
    Olvera-Rodríguez V; Barrera Garibay AC; Domínguez-Cherit J
    Skin Appendage Disord; 2022 Nov; 8(6):492-496. PubMed ID: 36407640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paroxysmal dystonic choreoathetosis with symptomatic seizures secondary to hypoglycemia caused by insulinoma.
    Gupta M; Batra A; Hirve M; Chowdhury D; Khwaja GA; Mishra PK
    Ann Indian Acad Neurol; 2011 Oct; 14(4):313-5. PubMed ID: 22346027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Insulinoma masquerades as epilepsy - quantitative EEG analysis.
    Kostolanska N; Klimes P; Kocvarova J; Pikulova H; Strycek O; Brazdil M; Dolezalova I
    Front Neurol; 2024; 15():1371055. PubMed ID: 38595852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent falls and confusion: recurrent hypoglycemia in a patient with tuberous sclerosis complex.
    Comninos AN; Yang L; Abbara A; Dhillo WS; Bassett JHD; Todd JF
    Clin Case Rep; 2018 May; 6(5):904-909. PubMed ID: 29744084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.
    Liu C; Lele SM; Goodenberger MH; Reiser GM; Christiansen AJ; Padussis JC
    BMC Med Genomics; 2024 May; 17(1):144. PubMed ID: 38802873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures.
    Lechuga L; Franz DN
    Expert Rev Neurother; 2019 Oct; 19(10):913-925. PubMed ID: 31335226
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.
    Curatolo P; Nabbout R; Lagae L; Aronica E; Ferreira JC; Feucht M; Hertzberg C; Jansen AC; Jansen F; Kotulska K; Moavero R; O'Callaghan F; Papavasiliou A; Tzadok M; Jóźwiak S
    Eur J Paediatr Neurol; 2018 Sep; 22(5):738-748. PubMed ID: 29880258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinoma in pediatric tuberous sclerosis complex: a case report.
    Librandi K; Grimaldi S; Catalano S; Moro F; Vallero SG; Spada M; Porta F
    Front Pediatr; 2023; 11():1216201. PubMed ID: 37601129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IS THERE A RELATIONSHIP BETWEEN TUBEROUS SCLEROSIS COMPLEX AND INSULINOMA?
    Piskinpasa H; Dogansen SC; Metin D; Gumusoglu AY; Altinay S; Sipahi M; Dogan B; Apaydin S
    Acta Endocrinol (Buchar); 2022; 18(3):350-354. PubMed ID: 36699161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Self-Injurious Behavior, Aggression, and Psychogenic Non-Epileptic Seizures in Patients With Tuberous Sclerosis: A Case Report With a Review of Literature.
    Ortiz JF; Ruxmohan S; Gomez J; Lalama HA; Taylor A; Smith DW
    Cureus; 2020 Nov; 12(11):e11715. PubMed ID: 33391947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
    Kang MY; Yeoh J; Pondicherry A; Rahman H; Dissanayake A
    J Endocr Soc; 2017 Sep; 1(9):1120-1123. PubMed ID: 29264566
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.